Tablets Motrin 250 mg,

Motrin tab.

250mg No. 20

Name ENG

MOTRIN

Clinical and pharmacological group

NSAIDs

ATX code

Naproxen

Dosage

250mg

Structure

One tablet contains:

.active substance: naproxen in terms of 100% substance - 250.00 mg

auxiliary substances: lactose monohydrate - 71.12 mg, potato starch - 42.00 mg, povidone - 16.00 mg, magnesium stearate - 0.76 mg, tropeolin O dye - 0.12 mg.

Indications

Pain syndrome of mild and moderate severity: neuralgia, ossalgia, myalgia, lumbar ischialgia, post-traumatic pain syndrome (sprains and bruises), accompanied by inflammation, postoperative pain (in traumatology, orthopedics, gynecology, maxillofacial surgery), headache, migraine, algodischialgia adnexitis, toothache.

Symptomatic therapy of pain syndrome in diseases of the musculoskeletal system, including bursitis, tendovaginitis.

As part of the complex therapy of infectious and inflammatory diseases of the ear, throat, nose with severe pain syndrome (pharyngitis, tonsillitis, otitis media).

Feverish conditions with flu and colds.

The drug is used for symptomatic therapy (to reduce pain, inflammation and reduce fever) and does not affect the progression of the underlying disease.

Storage conditions and periods

In a dry, dark place at a temperature not exceeding 25 degrees.

Expiration date: 3 years

Contraindications

Hypersensitivity to naproxen or naproxen sodium complete or incomplete combination of bronchial asthma, recurrent polyposis of the nose and paranasal sinuses, and intolerance to acetylsalicylic acid or other non-steroidal anti-inflammatory drugs (including a history). During the period of coronary artery bypass grafting. Erosive and ulcerative lesions of the stomach and 12 duodenal ulcer in the acute phase (ulcerative colitis (UC), Crohn's disease). Cerebrovascular bleeding or other bleeding and hemostasis disorders. Severe renal failure (creatinine clearance less than 30 ml / min), incl. confirmed hyperkalemia, progressive kidney disease. Oppression of bone marrow hematopoiesis. Pregnancy, breastfeeding period. Children up to age 12.

With caution Ischemic heart disease, cerebrovascular disease, congestive heart failure, dyslipidemia / hyperlipidemia, diabetes mellitus, peripheral arterial disease, smoking, creatinine clearance - 30-60 ml / min, anamnestic data on the development of ulcerative lesions of the gastrointestinal tract, the presence of Helicobacter infection pylori, advanced age, long-term use of non-steroidal anti-inflammatory drugs, frequent alcohol consumption, severe physical illness, concomitant therapy with the following drugs: anticoagulants (eg, warfarin), antiplatelet agents (acetylsalicylic acid, clopidogrel), oral glucocorticosteroids (eg, prednisone inhibitors) seizure of serotonin (citalopram, fluoxetine, paroxetine, sertraline).To reduce the risk of developing adverse events from the gastrointestinal tract, the minimum effective dose should be used in the minimum possible course. Children under the age of 16.

INN / Active ingredient

Naproxen

Specifications

Category

Preparations for the gastrointestinal tract

Scope of the drug

Musculoskeletal system

,

Ear, Throat, Nose

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

twenty

Scope of application

Dentistry

,

Traumatology

,

Surgery

Minimum age from

12 years

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Motrin

The amount of the dosage form in the primary package

10 pieces.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

NSAIDs

Anatomical and therapeutic characteristics

M01AE02 Naproxen

Dosage form

Pills

Expiration date in days

1095

Dosage (volume) of the substance in the preparation

naproxen in terms of 100% substance - 250.00 mg

Package weight, g

twenty

Mode of application

:

Inside, adults and children over 12 years old.

The tablets should be taken whole with a sufficient amount of liquid, can be taken with meals.

< br>

For pain relief, the starting dose is 500 mg, followed by 500 mg every 12 hours or 250 mg every 8 hours if necessary.

< br>

The usual daily dose used for pain relief is 500 to 1000 mg.

< br>

To relieve migraine pain, a dose of 500 mg twice a day is recommended.

However, treatment should be discontinued if the frequency, intensity and duration of migraine attacks do not decrease within 4-6 weeks.

< br>

To relieve menstrual pain, pain after the introduction of an intrauterine device and other gynecological pains (adnexitis), the initial dose is 500 mg, then, if necessary, 250 mg every 6-8 hours for 3-4 days.

< br>

For symptomatic treatment of pain in diseases of the musculoskeletal system (bursitis, tendovaginitis), the usual daily dose of the drug is 500-1000 mg, one or two tablets twice a day in the morning and in the evening.

< br>

When using the drug as an antipyretic agent, the initial dose is 500 mg, then, if necessary, 250 mg every 8 hours.

The drug is not recommended to be used as an anesthetic for more than 5 days without consulting a doctor.

If symptoms persist, seek medical attention.

Information on technical characteristics, delivery set, country of manufacture